Department of Upper Gastrointestinal Surgery, Royal Prince Alfred Hospital, 50 Missenden Road, Camperdown, New South Wales, 2050, Australia.
Surgical Outcomes Research Centre (SOuRCe), The University of Sydney, Sydney, New South Wales, 2006, Australia.
Langenbecks Arch Surg. 2021 Jun;406(4):1057-1069. doi: 10.1007/s00423-021-02116-w. Epub 2021 Mar 26.
Surgical resection for elderly patients with gastric cancer is controversial. This study aims to evaluate the preoperative features and postoperative short- and long-term outcomes of elderly patients following surgical resection for gastric adenocarcinoma.
Between January 2000 and May 2018, a total of 177 consecutive patients underwent curative gastrectomy for gastric adenocarcinoma was retrospectively reviewed. Propensity score matching (PSM) analysis was used to balance confounding covariates between the elderly and non-elderly groups. Clinicopathological characteristics, intraoperative characteristics, postoperative complications and long-term survival outcomes including overall survival (OS) and Disease Specific Survival (DSS) were compared and analysed using the Kaplan-Meier log-rank test. Multivariate cox proportional hazards regression analysis of clinicopathological factors influencing survival were evaluated.
There were 50 patients in the elderly group (age ≥ 75 years) and 127 patients in the non-elderly group (age < 75 years). Elderly patients had more comorbid conditions (p < 0.001), lower albumin concentration (p = 0.034), lower haemoglobin levels (p = 0.001), and poorer renal function (p = 0.043). TNM stage was similar between both groups (p = 0.174); however, lymphatic invasion (p = 0.006) and lymph node metastasis (p = 0.029) were higher in the elderly group. Elderly patients were much less likely to receive any chemo- (p < 0.001) or radiotherapy treatment (p = 0.007) with surgical treatment. After PSM, there were 50 patients in each group. Elderly patients were more likely to develop complications (Clavien Dindo ≥ 2: 50% vs. 26%, p = 0.003). The most common postoperative complications were pneumonia (12% vs. 6%, p = 0.498) and delirium (10% vs. 0%, p = 0.066). Elderly patients had a longer median length of hospital stay (median (IQR): 15.6(9.5) vs. 11.3 (9.9), p = 0.030). There were no differences in 30-day mortality (elderly vs. non-elderly: 1% vs. 1%, p = 0.988). Before and after PSM, age remains an independent predictor of postoperative complications. Before PSM, the estimated mean OS for the elderly and non-elderly patients were 108 months (95%CI, 72.5-143.5) and 143 months (95%CI, 123.0-163.8), respectively (p = 0.264). After PSM, the estimated mean OS for the elderly and non-elderly patients were 108 months (95%CI, 72.5-143.5) and 140 months (95%CI, 112.1-168.2), respectively, (p = 0.360). Before PSM, the estimated mean DSS for the elderly and non-elderly patients were 94 months (95%CI, 61.9-127.5) and 121 months (95%CI, 100.9-141.0), respectively (p = 0.405). After PSM, the estimated mean DSS for the elderly and non-elderly patients were 94 months (95%CI, 61.9-127.5) and 115 months (95%CI, 87.3-143.3), respectively (p = 0.721). Age was not an independent predictor of mortality following gastrectomy for gastric cancer in both PSM matched and unmatched cohort.
Chronological age alone is not a contraindication to curative resection of gastric adenocarcinoma in elderly patients with acceptable risk. Whilst age affects perioperative complications, the incidence of postoperative mortality and overall survival were not significantly different between elderly and non-elderly gastric cancer patients treated with curative surgery. Gastrectomy with D2 lymphadenectomy can also be performed in carefully selected elderly patients by surgeons with expertise in gastric resection along with appropriate perioperative management.
对于老年胃癌患者,手术切除存在争议。本研究旨在评估接受胃腺癌手术切除的老年患者的术前特征和术后短期及长期结局。
回顾性分析 2000 年 1 月至 2018 年 5 月期间,177 例连续接受胃腺癌根治性胃切除术的患者。采用倾向评分匹配(PSM)分析来平衡老年组和非老年组之间的混杂因素。比较并分析临床病理特征、术中特征、术后并发症以及总生存(OS)和疾病特异性生存(DSS)等长期生存结局,并使用 Kaplan-Meier 对数秩检验进行分析。采用多因素 Cox 比例风险回归分析评估影响生存的临床病理因素。
共有 50 例患者(年龄≥75 岁)归入老年组,127 例患者(年龄<75 岁)归入非老年组。老年组患者合并症更多(p<0.001),白蛋白浓度更低(p=0.034),血红蛋白水平更低(p=0.001),肾功能更差(p=0.043)。两组的 TNM 分期相似(p=0.174);然而,老年组的淋巴管侵犯(p=0.006)和淋巴结转移(p=0.029)更高。老年组患者接受化疗(p<0.001)和放疗(p=0.007)的可能性明显较低,仅接受手术治疗。PSM 后,每组各有 50 例患者。老年组患者发生并发症的可能性更高(Clavien Dindo≥2:50% vs. 26%,p=0.003)。最常见的术后并发症是肺炎(12% vs. 6%,p=0.498)和谵妄(10% vs. 0%,p=0.066)。老年组患者的中位住院时间更长(中位数(IQR):15.6(9.5) vs. 11.3(9.9),p=0.030)。30 天死亡率在两组之间无差异(老年 vs. 非老年:1% vs. 1%,p=0.988)。在 PSM 前后,年龄仍然是术后并发症的独立预测因素。在 PSM 前,老年和非老年患者的估计平均 OS 分别为 108 个月(95%CI,72.5-143.5)和 143 个月(95%CI,123.0-163.8)(p=0.264)。PSM 后,老年和非老年患者的估计平均 OS 分别为 108 个月(95%CI,72.5-143.5)和 140 个月(95%CI,112.1-168.2)(p=0.360)。PSM 前,老年和非老年患者的估计平均 DSS 分别为 94 个月(95%CI,61.9-127.5)和 121 个月(95%CI,100.9-141.0)(p=0.405)。PSM 后,老年和非老年患者的估计平均 DSS 分别为 94 个月(95%CI,61.9-127.5)和 115 个月(95%CI,87.3-143.3)(p=0.721)。年龄不是 PSM 匹配和不匹配队列中胃癌患者手术后死亡的独立预测因素。
在可接受风险的情况下,对于老年患者,单纯的年龄并不能作为胃腺癌根治性切除的禁忌证。虽然年龄会影响围手术期并发症,但在接受根治性手术治疗的老年和非老年胃癌患者中,术后死亡率和总体生存率并无显著差异。经验丰富的外科医生可以对精心选择的老年患者施行 D2 淋巴结清扫术,并进行适当的围手术期管理。